BCM
OSTX

Bridgeway Capital Management’s OS Therapies Inc OSTX Stock Holding History

Bridgeway Capital Management’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.3K Hold
25,000
– – ﹤0.01% 1197
2025
Q4 		$35K Hold
25,000
– – ﹤0.01% 1195
2025
Q3 		$49K Hold
25,000
– – ﹤0.01% 1170
2025
Q2 		$47K Buy
+25,000
New +$42.1K ﹤0.01% 1138

Other funds holding OSTX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bridgeway Capital Management's OSTX Position: Q1 2026 in Review

Bridgeway Capital Management held its OS Therapies Inc (OSTX) position steady in Q1 2026 at 25,000 shares worth $35.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1197.

Bridgeway Capital Management first reported a position in OSTX in Q2 2025 and has held it in 4 quarters since. The position peaked at $49K in Q3 2025. 29 funds tracked by Wall St. Rank hold OSTX as of Q1 2026.

  • Bridgeway Capital Management held 25,000 shares of OS Therapies Inc worth $35.3K as of Q1 2026.
  • Bridgeway Capital Management left its OS Therapies Inc share count unchanged in Q1 2026.
  • OS Therapies Inc made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #1197 holding.
  • Bridgeway Capital Management first reported a position in OS Therapies Inc in Q2 2025 and has held it in 4 quarters since.
  • Bridgeway Capital Management's OS Therapies Inc position peaked at $49K in Q3 2025.
  • 29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.